The role of STAT5 proteins in the regulation of normal hematopoiesis in a cord blood model

• Autorzy: Baskiewicz-Masiuk M , Masiuk M. , Czajka R. , Machalinski B.
• Języki publikacji: EN

Abstrakty

EN

The signal transducers and activators of transcription - STAT5A and STAT5B - are responsible for the control of proliferation, differentiation and apoptosis, via their effect on gene expression. They are activated by the binding of many cytokines, growth factors and hormones to their receptors on the cell surface. Many of these cytokines regulate hematopoietic cell development; therefore, STAT5 proteins are suggested to play an important role in hematopoiesis. There are numerous contradictory reports available in the literature on the role of STAT5 in normal hematopoietic cell development; hence, the question of the real function of STAT5 proteins clearly requires further studies. The aim of our study was to evaluate the role of STAT5 in normal hematopoiesis using oligodeoxynucleotide (ODN) strategy against STAT5 mRNA. We employed the RT-PCR method to study STAT5 mRNA expression in cells after their incubation with ODNs. We analyzed the effect of blocking STAT5 proteins on the viability and clonogenecity of the CFU-GM (Colony Forming Unit of Granulocyte-Macrophages) and the BFU-E (Burst Forming Unit of Erythrocytes) obtained from human cord blood (CB). The clonogenic growth of the cells was assessed in methylcellulose cultures according to the type of oligodeoxynucleotides. We also attempted to estimate the level of apoptosis induced in cord blood mononuclear and CD34+ cells by employing different assays: i) Annexin V staining using flow cytometry (FACSCalibur); ii) terminal deoxynucleotidyltransferase dUTP nick end labeling (TUNEL); iii) analysis of Bax and Bcl-XL gene expression by RT-PCR. Perturbation of STAT5 expression with antisense oligodeoxynucleotides had no impact on the viability, clonogenecity and apoptosis of CB hematopoietic cells. Our results showed that STAT5 proteins do not play a significant role in the regulation of proliferation of normal hematopoietic cells derived from cord blood.

Słowa kluczowe

EN

cord blood; hematopoiesis; living cell; regulation; apoptosis; oligodeoxynucleotide

• Wydawca: -
• Czasopismo: Cellular and Molecular Biology Letters
• Rocznik: 2003
• Tom: 08
• Numer: 2
• Opis fizyczny: p.317-331,fig.

Twórcy

autor

Baskiewicz-Masiuk M

• Pomeranian Medical University, Al.Powstancow Wlkp. 72, 70-111 Szczecin, Poland

autor

Masiuk M.

autor

Czajka R.

autor

Machalinski B.

Bibliografia

• 1.Leonard, W.J. Cytokine receptor signaling pathways. J. Allergy. Clin. Immunol. 105 (2000) 877-888.
• 2.Aaronson, D.S. and Horvath, C.M. A road map for those who don't know JAK-STAT. Science 296 (2002) 1653-1655.
• 3.Darnell, J. STATs and gene regulation. Science 277 (1997) 1630-1635.
• 4.Akira, S. Functional roles of STAT family proteins: Lessons from knockout mice. Stem Cells 17 (1999) 138-146.
• 5.Nosaka, T., Kawashima, T., Misawa, K., Ikuta, K., Mui, A. and Kitamura, T. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J. 18 (1999) 4754-4759.
• 6.Kieslinger, M., Woldman, I., Moriggl, R., Hofmann, J., Marine, J.C., Ihle, J.N., Beug, H. and Decker, T. Antiapoptotic activity of STAT5 required during terminal stages of myeloid differentiation. Genes Dev. 14 (2000) 232-244.
• 7.Bowman, T., Garcia, R., Turkson, J. and Jove, R. STATs in oncogenesis. Oncogene 19 (2000) 2474-2488.
• 8.Bromberg, J. and Darnell, J.E. Jr. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19 (2000) 2468- 2473.
• 9.Miyakawa, Y., Oda, A., Druker, B.J., Miyazaki, H., Handa, M, Ohashi, H. and Ikeda, Y. Thrombopoietin induces tyrosine phosphorylation of STAT3 and STAT5 in human blood platelets. Blood 87 (1996) 439-446.
• 10.Gouilleux, F., Pallard, C., Dusanter-Fourt, I., Wakao, H., Haldosen, L.A., Norstedt, G., Levy, D. and Groner, B. Prolactin, growth hormone, erythropoietin and granulocyte- macrophage colony stimulating factor induce MGF- STAT5 DNA binding activity. EMBO J. 14 (1995) 2005-2013.
• 11.Brizzi, M.F., Dentelli, P., Rosso, A., Yarden, Y. and Pegoraro, L. STAT protein recruitment and activation in c-Kit deletion mutants. J. Biol. Chem. 274 (1999) 16965-16972.
• 12.Zhang, S., Fukuda, S., Lee, Y., Hangoc, G., Cooper, S., Spolski, R., Leonard, W.J. and Broxmeyer, H.E. Essential role of signal transducer and activator of transcription (Stat) 5a but not Stat5b for Flt3- dependent signaling. J. Exp. Med. 192 (2000) 719-728.
• 13.Ward, A., Touw, I. and Yoshimura, A. The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood 95 (2000) 19-26.
• 14.Schwaller, J., Parganas, E., Wang, D., Cain, D., Aster, J.C., Wiliams, I.R., Lee, Ch., Gerthner, R., Kitamura, T., Frantsve, J., Anastasiadou, E., Loh, M. L., Levy, D.E., Ihle, J.N. and Gilliand, G. Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. Mol. Cell 6 (2000) 693-704.
• 15.Shuai, K., Halpern, J., Hoeve, J., Rao, X. and Sawyers, C.L. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13 (1996) 247-254.
• 16.Sillaber, C., Gesbert, F., Frank, D.A., Sattler, M. and Griffin, J.D. STAT5 activation contributes to growth and viability in Bcr/Abl- transformed cells. Blood 95 (2000) 2118-2125.
• 17.Chakaborty, A., Dyer, K.F. and Tweardy, D.J. Delineation and mapping of STAT5 isoforms activated by granulocyte colony- stimulating factor in myeloid cells. Blood Cells Mol. Dis. 26 (2000) 320-330.
• 18.Grimley, P.M., Dong, F. and Rui, H. Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation. Cytokine Growth Factor Rev. 10 (1999) 131-157.
• 19.Ambrosio, R. The structure of human STAT5A and STAT5B genes reveals two regions of nearly identical sequence and an alternative tissue specific STAT5B promoter. Gene 285 (2002) 311-318.
• 20.Socolovsky, M., Fallon, A.E., Wang, S., Brugnara, C. and Lodish, H.F. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 98 (1999) 181-191.
• 21.Socolovsky, M., Nam, H., Fleming, M.D., Haase, V.H., Brugnara, C. and Lodish, H.F. Ineffective erythropoiesis in STAT5a-/- 5b-/- mice due to decreased survival of early erythroblasts. Blood 98 (2001) 3261-3273.
• 22.Snow, J.W., Abraham, N., Ma, M.C., Abbey, N.W., Hemdier, B. and Goldsmith, M.A. STAT5 promotes multilineage hematolymphoid development in vivo through effects on early hematopoietic progenitor cells. Blood 99 (2002) 95-101.
• 23.Bradley, H.L., Hawley, T.S. and Bunting, K.D. Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. Blood 100 (2002) 3983-3989.
• 24.Teglund, S., Mckay, C., Schuetz, E., van Deursen, J.M., Stravopodis, D., Wang, D., Brown, M., Bodner, S., Grosveld, G. and Ihle, J.N. Stat5a and Stat5b proteins have essential and nonessential, or redundant roles in cytokine responses. Cell 29 (1998) 841-850.
• 25.Bunting, K.D., Bradley, H.L., Hawley, T.S., Moriggl, R., Sorrentino, B.P. and Ihle, J.N. Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5. Blood 99 (2002) 479-487.
• 26.Baśkiewicz-Masiuk, M., Masiuk, M., Domagała, W. and Machaliński, B. The role of STAT5 proteins in the regulation of normal hematopoiesis. Cell. Mol. Biol. Lett. 7 (2002) Suppl., 21.
• 27.Ratajczak, M.Z., Luger, S.M., DeRiel, K., Abrahm, J., Calabretta, B., Gewirtz, A.M. Role of the KIT protooncogene in normal and malignant human hematipoiesis. Proc. Natl. Acad. Sci. USA 89 (1992) 1710-1714.
• 28.Majka, M., Ratajczak, J., Machaliński, B., Carter, A., Pizzini, D., Wąsik, M.A., Gewirtz, A.M. and Ratajczak, M.Z. Expression, regulation and function of AC 133, a putative human haematopoietic cells. Folia Histochem. Cytobiol. 38 (2000) 53-63.
• 29.Caldenhoven, E., van Dijk, T.B., Tijmensen, A., Raaijmakers, J.A.M., Lammers, J.J., Koenderman, L. and de Groot, R. Differential activation of functionally distinct STAT5 proteins by Il-5 and GM-CSF during eosinophil and neutrophil differentiation from human CD34+ hematopoietic stem cells. Stem Cells 16 (1998) 397-403.
• 30.Buitenhuis, M., Baltus, B., Lammers, J-W.j., Coffer, P.J. and Koenderman, L. Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells. Blood 101 (2003) 134-142.
• 31.Luger, S.M., O'Brien, S.G., Ratajczak, J., Ratajczak, M.Z., Mick, R., Stadtmauer, E.A., Nowell, P.C., Goldman, J.M. and Gewirtz, A.M. Oligodeoxynucleotide-mediated inhibition of c-myc gene expression in autografted bone marrow: a pilot study. Blood 99 (2002) 1150-1158.
• 32.Gesbert, F. and Griffin, J.D. Bcr/Abl activates transcription of the Bcl-X gene through STAT5. Blood 96 (2000) 2269-2276.
• 33.Moulian, N., Truffault, F., Gaudry-Talarmain, Y.M., Serraf, A., Berrih-Aknin, S. In vivo and in vitro apoptosis of human thymocytes are associated with nitrotyrosine formation. Blood 97 (2001) 3521-3530.
• 34.Machaliński, B., Szołomicka, P., Kijowski, J., Baśkiewicz, M., Karbicka, A., Byra, E., Majka, M., Giedrys-Kalemba, S. and Ratajczak, M.Z. Short-term storage of human haematopoietic cells. Influence of air and deoxyribonuclease I. Annu. Transplant. 4 (1999) 29-36.
• 35.Ilaria. R.L., Hawley. R.G. and Van Etten. R.A. Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation. Blood 93 (1999) 4154-4166.
• 36.Israels, L. and Israels, E. Apoptosis. Stem Cells 17 (1999) 306-313.
• 37.Koopman, G., Reutelingsperger, C.P., Kuijten, G.A., Keehnen, R.M., Pals, S.T. and van Oers, M.H. Annexin V for flow cytometic detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84 (1994)1415-1420.
• 38.Traycoff, C.M., Abboud, M.R. and Laver, J. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts. Blood Cells 20 (1994) 382-390.
• 39.Laver, J., Duncan, E. and Abboud, M. High levels of granulocyte and granulocyte-macrophage colony-stimulating factors in cord blood of normal full-term neonates. J. Pediatr. 116 (1990) 627-632.
• 40.Lu, L., Xiao, M. and Shen, R.N. Enrichment, characterization and responsiveness of single primitive CD 34 human umbilical cord blood hematopoietic progenitors with high proliferative and replanting potential. Blood 81 (1993) 41-48.
• 41.Risdon, G., Gaddy, J. and Stehman, F.B. Proliferative and cytotoxic responses of human cord blood T lymphocytes following alogeneic stimulation. Cell. Immunol. 154 (1994) 14-24.
• 42.Hao, Q.L., Shah, A.J. and Thiemann, F.T. A functional comparison of CD34+ CD38- cells in cord blood and bone marrow. Blood 86 (1995) 3745- 3753.
• 43.Varizi, H., Dragowska, W. and Allsopp, R.C., Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA 91 (1994) 9857-9860.
• 44.Millot, G.A., Svinarchuh, F., Lacout, C., Vainchenker, W. and Dumenil, D. The granulocyte colony-stimulating factor receptor supports erythroid differentiation in the absence of the erythropoietin receptor or STAT5. Br. J. Haemat. 112 (2001) 449-458.